针对膜接触部位来调节脂质动态:创新的癌症治疗方法
Jie Wang1, Meifeng Wang2, Xueni Zeng2
1Department of Pathology and Institute of Oncology, The School of Basic Medical Sciences & Diagnostic Pathology Center, Fujian Medical University, University Town, Fuzhou, Fujian, 350122, China. helenajiewang@163.com.
Cell communication and signaling : CCS
|February 15, 2025
概括
膜接触部位 (MCS) 对于器官细胞通信和脂质运输至关重要. 癌细胞利用MCS改变脂质代谢,影响瘤的进展,并提供新的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 生物化学 生物化学
- 癌症研究 癌症研究
背景情况:
- 膜接触点 (MCS) 是专门的器官结点,促进分子交换和细胞平衡.
- 脂质的合成,新陈代谢和运输是重要的细胞过程,取决于器官的接近.
- 瘤微环境表现出对癌细胞存活和进展至关重要的动态脂质变化.
研究的目的:
- 分析癌细胞如何利用MCS调节脂质合成,新陈代谢和运输.
- 调查MCS介导的脂质动态对瘤进展的影响.
- 探索针对癌症中MCS相关的脂质代谢的治疗策略.
主要方法:
- 综合文献审查和对MCS和癌症中的脂质代谢现有研究的分析.
- 检查MCS形成和维持中的蛋白质参与.
- 在不同类型的癌症中对MCS和相关分子进行比较分析.
主要成果:
- 癌细胞战略性地利用MCS来调节脂质平衡,影响瘤生长和转移.
- 特定的MCS蛋白质和脂质通路在各种癌症中受到不同的调节.
- 针对MCS依赖的脂质代谢,为新型抗癌疗法提供了一个有希望的途径.
结论:
- MCS在癌症脂质代谢中发挥着关键作用,推动瘤的进展.
- 了解癌症类型特定的MCS变化是开发有效疗法的关键.
- 针对MCS提供了一种新的抗癌药物开发策略,尽管存在挑战.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cell-surface Signaling
51.4K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
51.4K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Mechanisms of Membrane Domain Formation
3.0K
Different physical properties of lipids and proteins allow them to localize and form distinct islands or domains in the membrane. Some membrane domains are formed due to protein-protein interactions, whereas others are formed due to the presence of specific lipids such as sphingolipids and sterols—for example, large proteins, such as bacteriorhodopsin, aggregate and create distinct domains.
Another mechanism for membrane domain formation involves membrane proteins interacting with...
Another mechanism for membrane domain formation involves membrane proteins interacting with...
3.0K
Membrane Fluidity
10.9K
Membrane fluidity is explained by the fluid mosaic model of the cell membrane, which describes the plasma membrane structure as a mosaic of components—including phospholipids, cholesterol, proteins, and carbohydrates—that gives the membrane a fluid character.
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is...
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is...
10.9K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K


